<DOC>
	<DOCNO>NCT01515761</DOCNO>
	<brief_summary>The primary objective determine lead position lateral wall leave ventricle patient meet criterion cardiac resynchronization therapy play role determine myocardial function affect severity mitral regurgitation .</brief_summary>
	<brief_title>POsition Leads Advanced heaRt Failure : POLAR Study</brief_title>
	<detailed_description>This 6 month , multi-centered , blind , randomize study . Approximately 60 patient join study . Two group , base lead position , study thirty ( 30 ) patient randomize group .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject meet general indication implantable cardioverter defibrillator ( ICD ) LV systolic function â‰¤ 35 % define echocardiography . Subject moderate severe heart failure , define NYHA Class IIIIV least 90 day prior enrollment . Subject optimal pharmacological heart failure therapy least 30 day prior enrollment . Subject 12lead electrocardiogram ( ECG ) obtain 90 day prior enrollment document sinus rate &gt; 50 bpm PR interval &lt; 320 m measure two lead . 12 lead ECG leave bundle brunch block morphology QRS duration least 120 msec . Subject creatinine &lt; 2.5 mg/dL obtain 30 day prior enrollment . Subject leave ventricular ejection fraction &lt; 35 % echocardiogram 1 year prior enrollment . Subject willing capable undergoing device implant participate test associate clinical investigation . Subject life expectancy 180 day , per physician discretion . Subject age 18 , legal age give inform consent specific state national law . Subject right bundle branch block morphology 12lead ECG obtain 90 day prior enrollment . Subject previous cardiac resynchronization therapy , previous coronary venous lead , meet general indication antibradycardia pace define ventricular pacing &gt; 40 % pacemaker interrogation . Subject neuromuscular , orthopedic , noncardiac condition prevents normal , unsupported walking . Subject atrial tachyarrhythmia permanent ( i.e. , terminate spontaneously terminate medical intervention ) persistent ( i.e. , terminate medical intervention , terminate spontaneously ) within 30 day prior enrollment . Subject currently require dialysis . Subject severe chronic obstructive pulmonary disease ( COPD ) , define FEV1/FVC &lt; 60 % , defined physician . Subject myocardial infarction within 30 day prior enrollment coronary artery disease ( CAD ) surgical percutaneous correction perform within 30 day prior enrollment . Subject hypertrophic obstructive cardiomyopathy infiltrative cardiomyopathy ( e.g. , amyloidosis , sarcoidosis ) . Subject IV inotropic agent . Subject mitral valve prosthesis , mechanical aortic tricuspid prosthesis Subject enrol concurrent study , without Medtronic write approval , may confound result study . Subject pregnant planning get pregnant . Subject require oxygen medical reason CHF .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>